News
Today, the value of this approach is widely recognised even by most pharmaceutical companies, a number of which – including Sanofi, Roche and Genentech, Bayer, and Merck KgaA – have partnered with ...
10d
Interesting Engineering on MSNMIT’s next-gen AI screens millions of molecules at supercomputer speed for drug study
Boltz 2 helps pharma triage vast molecular libraries, turning compute heavy screening into near real time decisions.
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is using AI to build a detailed digital model of a cell by combining various types of biological data, including patient data from Tempus and Helix.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results